Tech Company Financing Transactions

Kalidex Pharmaceuticals Funding Round

Kalidex Pharmaceuticals, based in Menlo Park, received $251 thousand from Frazier Healthcare Partners and private investors.

Transaction Overview

Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$251,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
70 Willow Road 200
Menlo Park, CA 94025
USA
Email Address
Not Recorded
Overview
Kalidex Pharmaceuticals, Inc is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms.
Profile
Kalidex Pharmaceuticals LinkedIn Company Profile
Social Media
Kalidex Pharmaceuticals Company Twitter Account
Company News
Kalidex Pharmaceuticals News
Facebook
Kalidex Pharmaceuticals on Facebook
YouTube
Kalidex Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Yigong Ge
  Yigong Ge LinkedIn Profile  Yigong Ge Twitter Account  Yigong Ge News  Yigong Ge on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2010: TimeSight Systems venture capital transaction
Next: 12/31/2010: NovaTorque venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary